Global Health Ltd
Global Health Ltd (MEDANTA) last reported results for the quarter ended Jun 2026, with sales of ₹1,304 crore and net profit of ₹157 crore. The stock last traded at ₹1,302, a market capitalisation of ₹35,007 crore, on a P/E of 61.2. Over the past 52 weeks the stock has ranged between ₹955 and ₹1,544. Figures are as of 6 Oct 2026 and are not real time.
Global Health Ltd share price and key metrics
- Current price
- ₹1,302
- Market cap
- ₹35,007 cr
- Stock P/E
- 61.2
- Book value
- ₹147
- ROE
- 15.2%
- ROCE
- 17.4%
- Dividend yield
- 0.04%
- 52w high / low
- 1544/955
Metrics as of 6 Oct 2026. Not real time.
Track Global Health Ltd
Cruxal reads every Global Health Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Global Health Ltd growth and returns
- 10 Years
- 12%
- 5 Years
- 25%
- 3 Years
- 18%
- TTM
- 21%
- 10 Years
- 13%
- 5 Years
- 81%
- 3 Years
- 19%
- TTM
- 0%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 21%
- 1 Year
- -2%
- 10 Years
- %
- 5 Years
- 16%
- 3 Years
- 16%
- Last Year
- 15%
Global Health Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹1,304 cr, up 26.5% from ₹1,031 cr a year earlier. Net profit was ₹157 cr, down 1.3% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 957 | 943 | 931 | 1,031 | 1,099 | 1,121 | 1,159 | 1,304 |
| Expenses | 728 | 706 | 707 | 784 | 868 | 904 | 915 | 1,017 |
| Operating profit | 228 | 238 | 225 | 247 | 231 | 217 | 244 | 287 |
| OPM % | 24% | 25% | 24% | 24% | 21% | 19% | 21% | 22% |
| Other income | 18 | 16 | -27 | 20 | 36 | -15 | 37 | 22 |
| Interest | 16 | 16 | 15 | 14 | 17 | 22 | 27 | 27 |
| Depreciation | 49 | 48 | 49 | 45 | 50 | 61 | 67 | 69 |
| Profit before tax | 181 | 189 | 133 | 208 | 200 | 120 | 187 | 213 |
| Tax % | 28% | 24% | 24% | 24% | 21% | 21% | 24% | 26% |
| Net profit | 131 | 143 | 101 | 159 | 158 | 95 | 142 | 157 |
| EPS (₹) | 4.87 | 5.32 | 3.78 | 5.92 | 5.89 | 3.54 | 5.36 | 5.90 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Global Health Ltd annual results
| ₹ crore | Mar 2016 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,382 | 1,343 | 1,456 | 1,500 | 1,447 | 2,167 | 2,710 | 3,275 | 3,692 | 4,410 | 4,683 |
| Operating profit | 301 | 125 | 172 | 192 | 197 | 458 | 637 | 809 | 886 | 930 | 979 |
| OPM % | 22% | 9% | 12% | 13% | 14% | 21% | 24% | 25% | 24% | 21% | 21% |
| Net profit | 170 | 33 | 51 | 36 | 29 | 196 | 326 | 478 | 481 | 554 | 552 |
| EPS (₹) | 35.10 | 6.78 | 10.44 | 7.36 | 5.81 | 7.75 | 12.16 | 17.81 | 17.92 | 20.70 | 20.69 |
TTM is the trailing twelve months to the most recent quarter.
Global Health Ltd balance sheet
| ₹ crore | Mar 2016 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 48 | 48 | 49 | 49 | 50 | 51 | 54 | 54 | 54 | 54 |
| Reserves | 976 | 1,136 | 1,246 | 1,300 | 1,333 | 1,565 | 2,375 | 2,852 | 3,333 | 3,908 |
| Borrowings | 165 | 456 | 787 | 929 | 931 | 1,109 | 1,122 | 802 | 718 | 1,190 |
| Other liabilities | 295 | 343 | 347 | 388 | 380 | 421 | 547 | 572 | 662 | 753 |
| Total liabilities | 1,485 | 1,984 | 2,430 | 2,666 | 2,694 | 3,146 | 4,097 | 4,280 | 4,766 | 5,905 |
| Fixed assets | 914 | 1,094 | 1,194 | 1,703 | 1,616 | 1,776 | 2,050 | 2,236 | 2,514 | 3,795 |
| CWIP | 12 | 317 | 666 | 382 | 464 | 439 | 327 | 388 | 533 | 132 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 3 |
| Other assets | 559 | 573 | 570 | 581 | 615 | 930 | 1,720 | 1,656 | 1,716 | 1,975 |
| Total assets | 1,485 | 1,984 | 2,430 | 2,666 | 2,694 | 3,146 | 4,097 | 4,280 | 4,766 | 5,905 |
As reported by the company. Total assets equal total liabilities by construction.
Global Health Ltd cash flow
| ₹ crore | Mar 2016 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 228 | 63 | 166 | 175 | 242 | 311 | 645 | 612 | 624 | 714 |
| Cash from investing | -241 | -69 | -249 | -87 | -239 | -421 | -342 | -441 | -721 | -1,089 |
| Cash from financing | -7 | 9 | 97 | -1 | -81 | 160 | 346 | -514 | -97 | 272 |
| Net cash flow | -20 | 3 | 14 | 87 | -78 | 50 | 648 | -343 | -194 | -103 |
| Free cash flow | 71 | -81 | -133 | -13 | 100 | 38 | 409 | 335 | 110 | -123 |
| CFO / operating profit | 108% | 93% | 135% | 121% | 131% | 89% | 118% | 98% | 89% | 90% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Global Health Ltd operating ratios
| Per year | Mar 2016 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | — | — | 6% | 6% | 5% | 15% | 17% | 20% | 20% | 17% |
| Debtor days | 20 | 41 | 41 | 36 | 34 | 30 | 26 | 24 | 29 | 34 |
| Inventory days | 28 | 26 | 26 | 43 | 42 | 36 | 35 | 32 | 28 | 29 |
| Days payable | 92 | 124 | 142 | 147 | 138 | 90 | 114 | 90 | 81 | 89 |
| Cash conversion cycle | -45 | -56 | -75 | -67 | -62 | -24 | -52 | -34 | -24 | -26 |
| Working capital days | -23 | -33 | -18 | -31 | -48 | -20 | -37 | -32 | -21 | -7 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Global Health Ltd shareholding pattern
Promoters held 33.00% at Jun 2026, broadly unchanged since Jun 2025. FIIs 9.46% and DIIs 16.89%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 33.04% | 33.03% | 33.03% | 33.01% | 33.01% | 33.01% | 33.01% | 33.00% |
| FIIs | 12.21% | 12.48% | 11.76% | 11.54% | 11.41% | 10.54% | 10.15% | 9.46% |
| DIIs | 11.11% | 10.51% | 11.93% | 12.20% | 12.97% | 13.99% | 14.76% | 16.89% |
| Public | 43.64% | 43.98% | 43.28% | 43.19% | 42.56% | 42.41% | 42.01% | 40.55% |
| No. of shareholders | 1,49,722 | 1,48,633 | 1,54,688 | 1,56,372 | 1,55,806 | 1,51,241 | 1,47,390 | 1,40,531 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Global Health Ltd corporate filings
- Global Health Ltd receives ESG rating from Crisil ESG Ratings & Analytics LimitedCompany Updatelow impact
Cruxal's analysis: On October 5, 2026, Global Health Ltd, a mid-cap company with a market cap of…
Read the full analysis - Global Health Limited (Medanta) to expand Delhi-NCR footprint with 165.82 crore land acquisition in GhaziabadCompany Updatehigh impact
Cruxal's analysis: Global Health Limited has acquired a 10,560 square metre land parcel in Siddharth Vihar…
Read the full analysis - Global Health Ltd: Routine Regulatory Intimation Under Regulation 30Company Updatelow impact
Cruxal's analysis: Global Health Ltd has filed a routine intimation under Regulation 30 of the SEBI (Listing…
Read the full analysis - Intimation regarding closure of Trading Window for the Second Quarter ended on September 30, 2026.Insider Trading / SASTlow impact
- Global Health Ltd schedules institutional investor meetingCompany Updatelow impact
Cruxal's analysis: Global Health Ltd has issued an intimation regarding a scheduled meeting with…
Read the full analysis - Global Health Ltd announces allotment of equity shares under ESOP schemeCompany Updatelow impact
Cruxal's analysis: Global Health Ltd has formally intimated the allotment of equity shares pursuant to the…
Read the full analysis - Global Health Ltd schedules institutional investor meetingCompany Updatelow impact
Cruxal's analysis: Global Health Ltd has issued a regulatory intimation regarding a scheduled meeting with…
Read the full analysis - Global Health Limited announces successful conclusion of 22nd AGM with shareholder approval for final dividendAGM/EGMlow impact
Cruxal's analysis: Global Health Limited has successfully concluded its 22nd Annual General Meeting held on…
Read the full analysis - Global Health Limited Concludes 22nd Annual General Meeting; Declares Final Dividend of 0.50 INR Per ShareAGM/EGMlow impact
Cruxal's analysis: Global Health Limited has successfully concluded its 22nd Annual General Meeting, where…
Read the full analysis - Global Health Ltd schedules institutional investor meetingCompany Updatelow impact
Cruxal's analysis: Global Health Ltd has issued an intimation regarding a scheduled meeting with…
Read the full analysis - Global Health Ltd announces schedule for institutional investor meetingCompany Updatelow impact
Cruxal's analysis: Global Health Ltd has filed an intimation regarding a scheduled meeting with…
Read the full analysis - Global Health Ltd schedules institutional investor meetingCompany Updatelow impact
Cruxal's analysis: Global Health Ltd has issued an intimation regarding a scheduled meeting with…
Read the full analysis - Global Health Ltd schedules institutional investor meetingCompany Updatelow impact
Cruxal's analysis: Global Health Ltd has issued an intimation regarding a scheduled meeting with…
Read the full analysis - Global Health Ltd schedules institutional investor meetingCompany Updatelow impact
Cruxal's analysis: Global Health Ltd has issued an intimation regarding a scheduled meeting with…
Read the full analysis - Global Health Ltd schedules institutional investor meetingCompany Updatelow impact
Cruxal's analysis: Global Health Ltd has issued a regulatory intimation regarding a scheduled meeting with…
Read the full analysis - Global Health Ltd schedules institutional investor meetingCompany Updatelow impact
Cruxal's analysis: Global Health Ltd has issued an intimation regarding a scheduled meeting with…
Read the full analysis - Global Health Ltd schedules institutional investor meetingCompany Updatelow impact
Cruxal's analysis: Global Health Ltd has issued an intimation regarding a scheduled meeting with…
Read the full analysis - Global Health Ltd schedules institutional investor meetingCompany Updatelow impact
Cruxal's analysis: Global Health Ltd has issued a routine intimation regarding a scheduled meeting with…
Read the full analysis - Global Health Ltd schedules institutional investor meetingCompany Updatelow impact
Cruxal's analysis: Global Health Ltd has issued an intimation regarding a scheduled meeting with…
Read the full analysis - Global Health Ltd schedules institutional investor meetingCompany Updatelow impact
Cruxal's analysis: Global Health Ltd has issued an intimation regarding a scheduled meeting with…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.